ArticlePharmaceutics2021

Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application.

Gábor Katona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.